Trial intelligence / Profile preview

Voltaren Real-World Study in Knee Osteoarthritis

2024-510839-22-00Phase 4Completed

Sponsor
Haleon
Start
Jul 2024
Modality
Small Molecules
Countries
2
01

Overview

Phase 4, open-label, single-arm trial of diclofenac in knee osteoarthritis (OA), sponsored by Haleon. Primary endpoint: Change from baseline in average minutes of moderate and vigorous physical activity (MVPA). Started Jul 2024; status: completed.

02

Drugs

diclofenac
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on 2024-510839-22-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-510839-22-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call